Results 191 to 200 of about 179,985 (317)

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Automated vs. manual segmentation for small renal mass imaging. [PDF]

Can Urol Assoc J
McAlpine K, Mirajkar N, Deniffel D, Kohan A, Krishna S, Kulkarni G, Seto E, Finelli A, Haider MA.   +8 more
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Radiologists' memory as a data protection risk: a worst-case stress test for chest radiograph re-identification. [PDF]

Insights Imaging
Fink MA, Römer C, Ebel M, Frodl E, Dos Santos DP, Kauczor HU, Bucher A.   +6 more
europepmc   +1 more source

Cascade mentoring: a proposal for transforming radiology education in line with the European training curriculum. [PDF]

Insights Imaging
Vieira A, Vieira AC.
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Could Pretreatment Computed Tomography Imaging Accurately Predict the Pathological Diagnosis of Lymph Node Involvement in Thymic Epithelial Tumors? [PDF]

World J Oncol
Liu HY, Chen MC, Chen JY, Lee WJ, Lee JM.   +4 more
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

AI in Lung Nodules on Chest CT: Retrospective, Real-World Assessment of AI in Clinical Practice. [PDF]

JMIR Form Res
Sodhi-Kalra H, Jha S, Digumarthy S.
europepmc   +1 more source

Under-recognized, under-referred: a multidisciplinary evaluation of fragility fracture management in the emergency setting. [PDF]

Arch Osteoporos
Bertoldo F, De Iaco F, Trevisan C, Marcellusi A, Viapiana O, Baggio G, De Conti G, Silveri F, Cocorocchio A, Giannini S.   +9 more
europepmc   +1 more source